Distinguished in Frontotemporal Dementia

Morris Freedman

Mt. Sinai, 
Toronto, ON, CA 
Clinical Trials:Currently Recruiting for 1 Trial
Distinguished in Frontotemporal Dementia
Mt. Sinai, 
Toronto, ON, CA 
OverviewLocationsClinical Research

Overview

Morris Freedman practices in Toronto, Canada. Mr. Freedman is rated as a Distinguished expert by MediFind in the treatment of Frontotemporal Dementia. His top areas of expertise are Frontotemporal Dementia, Dementia, Alzheimer's Disease, and Developmental Dysphasia Familial.

His clinical research consists of co-authoring 88 peer reviewed articles and participating in 4 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 22 articles in the study of Frontotemporal Dementia.

Gender
Male

Locations

Mt. Sinai, Toronto, ON, Canada

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

4 Clinical Trials

The Brain Eye Amyloid Memory (BEAM) Study: Validation of Ocular Measures as Potential Biomarkers for Early Detection of Brain Amyloid and Neurodegeneration
The Brain Eye Amyloid Memory (BEAM) Study: Validation of Ocular Measures as Potential Biomarkers for Early Detection of Brain Amyloid and Neurodegeneration
Enrollment Status: Recruiting
Publish Date: April 22, 2024
Intervention Type: Other
The SARTAN-AD Trial: A Randomized, Open Label, Proof of Concept Study of Telmisartan vs. Perindopril in Mild-Moderate Alzheimer's Disease Patients
The SARTAN-AD Trial: A Randomized, Open Label, Proof of Concept Study of Telmisartan vs. Perindopril in Mild-Moderate Alzheimer's Disease Patients
Enrollment Status: Terminated
Publish Date: May 06, 2025
Intervention Type: Drug
Study Drugs: Perindopril, Telmisartan
Study Phase: Phase 2
A Pilot Randomized Controlled Trial of an At-home Mindfulness Meditation Intervention in Older Adults With Mild Cognitive Impairment and in Family Caregivers
A Pilot Randomized Controlled Trial of an At-home Mindfulness Meditation Intervention in Older Adults With Mild Cognitive Impairment and in Family Caregivers
Enrollment Status: Terminated
Publish Date: March 02, 2022
Intervention Type: Behavioral
Study Phase: Not Applicable
Low Dose Ionizing Radiation Using CT Scans as a Potential Therapy for Alzheimer's Dementia (LDIR-CT-AD) Trial: A Pilot Study
Low Dose Ionizing Radiation Using CT Scans as a Potential Therapy for Alzheimer's Dementia (LDIR-CT-AD) Trial: A Pilot Study
Enrollment Status: Completed
Publish Date: March 02, 2022
Intervention Type: Radiation
Study Phase: Not Applicable
View 3 Less Clinical Trials

88 Total Publications

Delineating the Effects of Alcohol Use on Cognition in Individuals With Neurocognitive Disorders.
Delineating the Effects of Alcohol Use on Cognition in Individuals With Neurocognitive Disorders.
Journal: The Journal of clinical psychiatry
Published: August 06, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Freedman's expertise for a condition
ConditionClose
    View All 7 Advanced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile